Enjuvia Alternatives Compared
| Enjuvia (conjugated estrogens) | Medroxyprogesterone | Norethindrone |
|
|---|
| Enjuvia (conjugated estrogens) | Medroxyprogesterone | Norethindrone |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Atrophic Vaginitis, Abnormal Uterine Bleeding, Atrophic Urethritis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian... View more |
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometrial Hyperplasia - Prophylaxis, Amenorrhea, Endometrial Cancer, Birth Control, Endometriosis, Gender Affirming Hormone Therapy, Gender Dysphoria... View more |
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometriosis, Amenorrhea, Gender Affirming Hormone Therapy, Birth Control. Norethindrone may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Enjuvia (conjugated estrogens) | More about Medroxyprogesterone | More about Norethindrone | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Enjuvia has an average rating of 7.4 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
Medroxyprogesterone has an average rating of 4.5 out of 10 from a total of 2469 ratings on Drugs.com. 30% of reviewers reported a positive effect, while 51% reported a negative effect. |
Norethindrone has an average rating of 4.9 out of 10 from a total of 1570 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Enjuvia side effects |
View all Medroxyprogesterone side effects |
View all Norethindrone side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Medroxyprogesterone prices |
View all Norethindrone prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other conjugated estrogens brands include: Premarin, Premarin Intravenous | Depo Provera, depo-subQ provera 104, Provera | Affodel, Camila, Deblitane, Emzahh, Errin, Gallifrey, Heather, Incassia, Jencycla, Lyleq, Lyza, Nor-QD, Norlyda, Norlyroc, Orquidea, Sharobel, Tulana View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
401 hours |
10 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 250 drugs are known to interact with Enjuvia:
|
A total of 248 drugs are known to interact with Medroxyprogesterone:
|
A total of 263 drugs are known to interact with Norethindrone:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
May 10, 2004 |
June 18, 1959 |
April 21, 1982 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.